SMAD4 and neoplasm: It was observed that selective SMAD4 deletion in the pancreatic epithelium had no discernable impact on pancreatic development or physiology, but when combined with the activated KRASG12D allele, SMAD4 deficiency enabled rapid progression of KRASG12D-initiated neoplasms.